Mattia Benedet

Mattia Benedet trained as a molecular biologist at the University of Milan, earning a degree in Molecular Biology of the Cell and a Phd in Biomolecular Sciences.

During his PhD he worked to the characterization of the lipopolysaccharide transport machinery, which is essential for the biogenesis of the outer membrane of Gram negative bacteria such as Escherichia coli and Pseudomonas aeruginosa and represents a potential target for the development of antibiotics.

Then, as a post-doc at the University of Trento, he studied the evolution in human of clinical isolates of Pseudomonas aruginosa and the elongation and cell division machinery of Streptococcus pneumoniae as a model for Gram-positive pathogen cocci.

Since 2020, first at the University of Trento and now at the Toscana Life Sciences Foundation, he has been working on the ERC VACCIBIOME project in the group directed by prof. Guido Grandi, contributing to the study of the relationship between the intestinal microbiota and the immune system with the aim of developing vaccines and immunotherapy treatments against cancer.